Details for New Drug Application (NDA): 020427
✉ Email this page to a colleague
The generic ingredient in SABRIL is vigabatrin. There are five drug master file entries for this compound. Seventeen suppliers are listed for this compound. Additional details are available on the vigabatrin profile page.
Summary for 020427
Tradename: | SABRIL |
Applicant: | Lundbeck Pharms Llc |
Ingredient: | vigabatrin |
Patents: | 0 |
Suppliers and Packaging for NDA: 020427
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
SABRIL | vigabatrin | TABLET;ORAL | 020427 | NDA | Lundbeck Pharmaceuticals LLC | 67386-111 | 67386-111-01 | 100 TABLET, FILM COATED in 1 BOTTLE (67386-111-01) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | TABLET;ORAL | Strength | 500MG | ||||
Approval Date: | Aug 21, 2009 | TE: | AB | RLD: | Yes |
Complete Access Available with Subscription